Literature DB >> 26034146

Use of Laser Speckle Contrast Imaging to Assess Digital Microvascular Function in Primary Raynaud Phenomenon and Systemic Sclerosis: A Comparison Using the Raynaud Condition Score Diary.

John D Pauling1, Jacqueline A Shipley2, Darren J Hart2, Anita McGrogan2, Neil J McHugh2.   

Abstract

OBJECTIVE: Evaluate objective assessment of digital microvascular function using laser speckle contrast imaging (LSCI) in a cross-sectional study of patients with primary Raynaud phenomenon (RP) and systemic sclerosis (SSc), comparing LSCI with both infrared thermography (IRT) and subjective assessment using the Raynaud Condition Score (RCS) diary.
METHODS: Patients with SSc (n = 25) and primary RP (n = 18) underwent simultaneous assessment of digital perfusion using LSCI and IRT with a cold challenge on 2 occasions, 2 weeks apart. The RCS diary was completed between assessments. The relationship between objective and subjective assessments of RP was evaluated. Reproducibility of LSCI/IRT was assessed, along with differences between primary RP and SSc, and the effect of sex.
RESULTS: There was moderate-to-good correlation between LSCI and IRT (Spearman rho 0.58-0.84, p < 0.01), but poor correlation between objective assessments and the RCS diary (p > 0.05 for all analyses). Reproducibility of IRT and LSCI was moderate at baseline (ICC 0.51-0.63) and immediately following cold challenge (ICC 0.56-0.86), but lower during reperfusion (ICC 0.3-0.7). Neither subjective nor objective assessments differentiated between primary RP and SSc. Men reported lower median daily frequency of RP attacks (0.82 vs 1.93, p = 0.03). Perfusion using LSCI/IRT was higher in men for the majority of assessments.
CONCLUSION: Objective and subjective methods provide differing information on microvascular function in RP. There is good convergent validity of LSCI with IRT and acceptable reproducibility of both modalities. Neither subjective nor objective assessments could differentiate between primary RP and SSc. Influence of sex on subjective and objective assessment of RP warrants further evaluation.

Entities:  

Keywords:  IMAGING; OUTCOMES MEASUREMENT; RAYNAUD PHENOMENON; REPRODUCIBILITY; SYSTEMIC SCLEROSIS

Mesh:

Year:  2015        PMID: 26034146     DOI: 10.3899/jrheum.141437

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Ricardo J Bello; Carisa M Cooney; Eitan Melamed; Keith Follmar; Gayane Yenokyan; Gwendolyn Leatherman; Ami A Shah; Fredrick M Wigley; Laura K Hummers; Scott D Lifchez
Journal:  Arthritis Rheumatol       Date:  2017-06-26       Impact factor: 10.995

Review 2.  Clinical Trial Design Issues in Systemic Sclerosis: an Update.

Authors:  Jessica K Gordon; Robyn T Domsic
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

3.  Choosing a model for laser speckle contrast imaging.

Authors:  Chang Liu; Kıvılcım Kılıç; Sefik Evren Erdener; David A Boas; Dmitry D Postnov
Journal:  Biomed Opt Express       Date:  2021-05-21       Impact factor: 3.732

Review 4.  The patient experience of Raynaud's phenomenon in systemic sclerosis.

Authors:  John D Pauling; Lesley Ann Saketkoo; Marco Matucci-Cerinic; Francesca Ingegnoli; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2019-01-01       Impact factor: 7.580

5.  Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.

Authors:  John D Pauling; Robyn T Domsic; Lesley A Saketkoo; Celia Almeida; Jane Withey; Hilary Jay; Tracy M Frech; Francesca Ingegnoli; Emma Dures; Joanna Robson; Neil J McHugh; Ariane L Herrick; Marco Matucci-Cerinic; Dinesh Khanna; Sarah Hewlett
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-08-16       Impact factor: 4.794

6.  An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.

Authors:  Murray Baron; Bashar Kahaleh; Elana J Bernstein; Lorinda Chung; Philip J Clements; Christopher Denton; Robyn T Domsic; Nava Ferdowsi; Ivan Foeldvari; Tracy Frech; Jessica K Gordon; Marie Hudson; Sindhu R Johnson; Dinesh Khanna; Zsuzsannah McMahan; Peter A Merkel; Sonali Narain; Mandana Nikpour; John D Pauling; Laura Ross; Antonia Maria Valenzuela Vergara; Alessandra Vacca
Journal:  J Scleroderma Relat Disord       Date:  2018-07-18

7.  Pharmacotherapy Options in the Management of Raynaud's Phenomenon.

Authors:  Alicia M Hinze; Fredrick M Wigley
Journal:  Curr Treatm Opt Rheumatol       Date:  2018-07-04

8.  Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease.

Authors:  E M McCarthy; D Moreno-Martinez; F L Wilkinson; N J McHugh; I N Bruce; J D Pauling; M Y Alexander; B Parker
Journal:  BBA Clin       Date:  2016-11-10

9.  Dual-Wavelength Laser Speckle Contrast Imaging (dwLSCI) Improves Chronic Measurement of Superficial Blood Flow in Hands.

Authors:  Lingke Zhang; Li Ding; Miao Li; Xiaoli Zhang; Diansan Su; Jie Jia; Peng Miao
Journal:  Sensors (Basel)       Date:  2017-12-05       Impact factor: 3.576

10.  Novel assessment tool based on laser speckle contrast imaging to diagnose severe ischemia in the lower limb for patients with peripheral arterial disease.

Authors:  Sotaro Katsui; Yoshinori Inoue; Kimihiro Igari; Takahiro Toyofuku; Toshifumi Kudo; Hiroyuki Uetake
Journal:  Lasers Surg Med       Date:  2017-04-02       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.